Stem Cell Treatment Demonstrates Potential To Enhance Motor Function In Spinal Cord Injury Patients

Researchers in Japan have reported promising results from a clinical study aimed at repairing spinal cord injuries using special stem cells. Two out of four patients who received transplants of these cells showed improvements in motor function. The study, conducted by Keio University and other institutions, marks the first instance where induced pluripotent stem cells (iPSCs) have been used successfully to enhance symptoms in such patients.

In this groundbreaking study, 2 million iPSC-derived cells were transplanted into each of the four participants, all of whom had lost movement and sensation due to spinal cord injuries. The researchers evaluated the extent of motor function recovery one year after the procedure. Encouragingly, two patients demonstrated significant improvements in their motor abilities.

An elderly man involved in an accident was among those who benefited from the treatment. He progressed from being unable to move to standing without assistance and even began practicing walking. His motor function score improved from the lowest rank of A to D on a scale ranging from A to E. Another patient also experienced an improvement, moving up two levels to C, enabling them to eat independently despite still being unable to stand.

The remaining two participants did not exhibit any noticeable recovery in motor functions. However, none of the four patients experienced serious health issues following the transplantation procedure. This outcome is particularly noteworthy as only about 10 percent of individuals with spinal cord injuries typically achieve a two-level improvement through rehabilitation alone.

The researchers assert that this is the first successful case where iPSC treatments have led to motor function recovery in spinal cord injury patients. In Japan, approximately 5,000 new cases of spinal cord injuries are reported annually. Given these promising results, the research team plans to conduct further clinical trials with the aim of obtaining government approval for this innovative treatment method.

The potential impact of this research is significant as it offers hope for improved quality of life for those affected by spinal cord injuries. By advancing towards government approval, these findings could pave the way for broader application and accessibility of iPSC-based treatments in medical practice.

With inputs from WAM